Iron Sucrose Injection USP is an intravenous iron medicine used to treat iron deficiency and iron-deficiency anemia, particularly in patients with chronic kidney disease.
Key Benefits
- Helps replenish depleted iron stores
- Supports the treatment of iron-deficiency anemia
- Helps increase iron availability for red blood cell production
- Commonly used for iron deficiency associated with chronic kidney disease
- Provides iron directly through intravenous administration when oral supplementation is inadequate
How It Works
Iron sucrose supplies iron directly into the bloodstream. The iron is gradually made available for incorporation into hemoglobin and other iron-containing proteins, supporting red blood cell production and helping restore the body's iron stores.
Common Side Effects
- Headache
- Nausea
- Dizziness
- Low blood pressure
- Injection-site irritation
- Muscle or joint discomfort
- Changes in taste
- Temporary flushing
Important Information
Iron Sucrose Injection USP should be administered intravenously by a qualified healthcare professional. Patients may be monitored during and after administration because hypersensitivity reactions can rarely occur. Blood tests such as hemoglobin, ferritin, and transferrin saturation may be used to assess iron status and treatment response. Iron overload should be avoided, and the medicine should be used only when iron deficiency has been appropriately established. Seek immediate medical attention if breathing difficulty, swelling, severe dizziness, chest discomfort, or other signs of a serious allergic reaction occur.